Adjusting Cochlear Implant Signals to Reduce Facial Nerve Stimulation
Tests changing implant electrical signals to limit facial nerve stimulation in adults with hearing loss.
Key facts
- Who runs it
- Cambridge University Hospitals NHS Foundation Trust
- Where
- United Kingdom1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Minimizing Facial Nerve Stimulation in Cochlear Implants
- Status
- Enrolling by invitation
- People taking part
- 24 people, planned
- Started
- 13 Dec 2019
- Expected to end
- 1 Nov 2028
- Type of study
- Interventional, 2 groups
- Treatments tested
- Electrical Stimulation
- Record updated
- 12 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with severe to profound hearing loss who use a cochlear implant in one ear, or who are about to get one. It studies how to set the implant so it stimulates the hearing nerve and not the facial nerve.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- Severe to profound hearing loss that started after the person learned to speak. Post-operative group: people whose implant also stimulates the facial nerve on one or more electrodes.
- Earlier treatment
- Post-operative group: has used a cochlear implant in one ear for at least 6 months. Intra-operative group: meets the NICE criteria to receive a cochlear implant.
Main reasons for not taking part
- Cochlear implant or hearing aid settings that are not stable
- Taking medicine on and off that might change hearing levels
- Thinking or psychological problems that might make attention vary
- Other handicaps that would get in the way of taking part, as judged by the lead doctor
- Not able to understand English well enough to give consent
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- Participant is willing and able to give informed consent for participation in the study; Male or Female, aged 18 years or above; Unilateral user of a cochlear implant or at least 6 months (post-operative group), or prospective CI user, meeting NICE criteria for implantation (intra-operative group); First language English or sufficiently fluent in English to understand the consenting process; Post-lingual onset of severe to profound hearing loss; No other handicaps that would interfere with participation in the study in the opinion of the Principal Investigator
Who cannot take part
- Unstable cochlear implant or hearing aid fitting; Using medication in an intermittent manner that might influence hearing levels; Cognitive or psychological challenges that might lead to variations in attention
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to understand how to manipulate the electrical stimulation from the cochlear implant to maximize hearing stimulation and minimize facial stimulation. It is know from animal data that the hearing and facial nerves have different sensitivities to things like electrical pulse shape, its pattern, and its duration. It is very unclear however if this applies to human cochlear implant patients, and what the optimal parameters are to selectively stimulate the hearing nerve in humans. The outcomes of this study will be used to more selectively program some patients with severe facial nerve cross stimulation and to inform the development of new types of implant stimulation.
The 2 groups in the trial
- IntraOperative GroupTreatment being tested
The intra-operative group consists of patients who have met criteria for cochlear implants. We monitor the facial nerve EMG intraoperatively in all patients, and often get some facial nerve activation when we are testing the implant intraoperatively when we are looking to see if we are getting any hearing nerve responses from electrical stimulation of the implant. We will also measure the facial nerve responses for some other charge-balanced pulse shapes, which are asymmetric and in which either the positive or negative charge is expected to stimulate the nerve. We will only measure these for two electrodes, not for all 12-22 electrodes They will be then invited back post operatively for a second testing during a standard of care visit post switch on for other pulse shapes.
Treatment: Electrical Stimulation
- PostOperative GroupTreatment being tested
The post-operative group, are patients who are actually having facial nerve stimulation on one or more electrodes, and for whom these electrodes are turned down so much they can't hear very well, or are actually turned off because of the facial nerve stimulation. For these patients, we will slowly increase the current levels on the offending electrodes (maximum of two) until they get some facial nerve twitching, and then turn down the current until they do not have stimulation any more. We will do this for all pulse shapes and determine which shape produces the greatest loudness without stimulating the facial nerve. This will be the only testing session for the second group.
Treatment: Electrical Stimulation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Minimizing Facial Nerve Stimulation in Cochlear Implants
- Plain-language title
- Adjusting Cochlear Implant Signals to Reduce Facial Nerve StimulationGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 12 November 2026